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The scope of the present work was to characterize the activity of class IIa bacteriocins in Listeria 
(L.) monocytogenes cells that constitutively express an activated form of PrfA, the virulence master 
regulator, since bacteriocin sensitivity was only characterized in saprophytic cells so far. The 
mannose phosphotransferase system (Man-PTS) has been shown to be the class IIa bacteriocin 
receptor in Listeria; hence, special attention was paid to its expression in virulent bacteria. 
Methods 
L. monocytogenes FBprfA* cells were obtained by transconjugation. Bacterial growth was studied 
in TSB and glucose containing-minimal medium. Sensitivity to antimicrobial peptides was assessed 
by killing curves. Membranes of L. monocytogenes FBprfA* cells were characterized using 
proteomic and lipidomic approaches. 
Results 
The mannose phosphotransferase system (Man-PTS) was downregulated upon expression of 
PrfA*, and these cells turned out to be more sensitive to enterocin CRL35 and pediocin PA-1, while 
not to nisin. Proteomic and lipidomic analysis showed differences between wild type (WT) and 
PrfA* strains. For instance, phosphatidic acid was only detected in PrfA* cells, whereas, there was 
a significant decline of plasmalogen-phosphatidylglycerol in the same strain. 
Conclusions 
Our results support a model in which Man-PTS acts just as a docking molecule that brings class IIa 
bacteriocins to the plasma membrane. Furthermore, our results suggest that lipids play a crucial 
role in the mechanism of action of bacteriocins. 
General Significance 
This is the first demonstration of the link between L. monocytogenes virulence and the bacterial 
sensitivity toward pediocin-like peptides.  
 
















Man-PTS mannose phosphotransferase system 
PBS Phosphate-buffered saline 
PrfA* cells cells expressing the PrfAL140F protein 
TE buffer Tris-EDTA buffer 
TSB Tryptone Soya Broth 
PA Phosphatidic Acid 















Bacteriocins from lactic acid bacteria are antimicrobial peptides that deserve significant attention 
since they have a promising future as food biopreservatives, and even as modifiers of the gut 
microbiota [1]. Among them, enterocin CRL35 was extensively characterized [2]. It has been 
proposed that all class IIa peptides interact with sensitive bacteria in a similar fashion, i.e. the 
positively charged N-terminal domain of these bacteriocins may bind to the N-terminal loop of the 
IIC subunit of the mannose phosphotransferase system (Man-PTS). It has been additionally 
proposed that not only IIC but also IID would then engage in helix–helix interactions with the C-
terminal domain of the bacteriocins during pore formation [3,4]. Lack of expression of the Man-PTS 
renders cells highly resistant to these peptides [5]. Diep et al. nicely presented the final model for 
the receptor and its interaction with the bacteriocin and the immunity protein [6]. In addition to the 
receptor, the physicochemical properties of the cell wall and the composition of the plasma 
membrane seem to play a role in the interaction between bacteriocins and target cells [7,8]. 
Interestingly, bacteriocins can interact and even disrupt membranes lacking the bacteriocin 
receptor [9]. However, much higher peptide concentrations are needed for inducing membrane 
leakage. Importantly, anionic phospholipids seem to be essential for proper binding of peptides to 
membranes in the absence of receptor [9–11]. 
Listeria monocytogenes can live as saprophyte in the environment. However, once ingested, this 
bacterium can switch its metabolism and undergo remarkable adaptations in order to survive and 
replicate within the host [12]. The most important factor mediating this transition is PrfA, the master 
regulator of Listeria virulence. It is well established that sugar PTS complexes can shutdown PrfA 
when bacteria are consuming these carbohydrates, e.g. during the saprophytic life style [13–15]. 
Conversely, a low activity of PTS systems is expected in cells expressing activated PrfA. 
Up to date, in vitro L. monocytogenes-related studies on class IIa bacteriocins action have been 
conducted with the organism in a saprophytic state, i.e. measuring bacterial growth and viability in 
regular culture media where no expression of virulence factors is detected whatsoever. Therefore, 
the main objective of the present study was to characterize the sensitivity of L. monocytogenes 
cells constitutively expressing active PrfA to pediocin-like peptides. Our working hypothesis was 














because of the attenuated expression or lower activity of the Man-PTS. However, we found the 
opposite result, which correlated with major changes not only in the profile of proteins associated 
to plasma membrane but also in the phospholipid composition of the membrane. 
 
2. MATERIAL AND METHODS 
2.1. Bacterial strains and growth conditions 
E. coli DH5α was used as a host strain for recombinant plasmids, whereas E. coli SM10, a kind gift 
from Dr. García Vescovi (IBR, Argentina), was used as the donor strain for the conjugation assay. 
Both strains were grown in Luria Broth (LB) medium at 37°C. The L. monocytogenes FBUNT strain 
is a 4b serotype isolated from the first clinical case of neonatal meningitis due to Listeria 
monocytogenes in the province of San Luis [16]; it expresses Man-PTS and was deposited at the 
Culture Collection of the Bacteriology Department from the Facultad de Bioquímica, Química y 
Farmacia - UNT (Tucumán, Argentina). The strain FBUNT, a clinical isolate, is sensitive to both 
enterocin CRL35 and pediocin PA-1; it has been extensively used in our lab [2,17,18] and its 
genome was recently sequenced (AN: NZ_PVZU00000000.1). In addition, we used the resistant 
isolates L. monocytogenes INS7 R2 and L. monocytogenes INS7 R3, as well as the parental 
sensitive strain L. monocytogenes INS7, that were recently characterized [19]. Unless stated 
otherwise, L. monocytogenes strains were routinely grown in TSB medium at 37°C. 
2.2. Generation of L. monocytogenes FBUNT with activated prfA allele 
The integration vector pNF1002 (pPL2-prfAL140F) was used for inducing L. monocytogenes 
FBUNT to constitutively express virulence factors [20]. For that purpose, 250 μl of pNF1002-
bearing E. coli SM10 culture were mixed with 150 μl of L. monocytogenes FBUNT. The bacterial 
mixture was put onto a 0.45-μm-pore-size HA-type filter (Millipore) on a Triptone Soy Broth (TSB) 
agar plate without antibiotics, and incubated at 30°C for 2 h. Afterward, cells were recovered in 2 
ml of TSB and 200 μl of bacterial suspension were mixed with 3 ml of LB top agar and overlaid 
onto TSB plates containing 7.5 μg.ml-1 of chloramphenicol and 25 μg.ml-1 of nalidixic acid. Plates 
were incubated overnight at 30°C and then shifted to 37°C for 2 days. Colonies were plated on 














performed to confirm the integration of the constitutively activated prfA allele, as described 
elsewhere [20]. The primers used were the following: 5′-GTCAAAACATACGCTCTTATC-3′ and 5′-
ACATAATCAGTCCAAAGTAGATGC-3′. The selected clone was named L. monocytogenes 
FBprfA*. The activated PrfA (L140F mutation) will be denoted as PrfA* in the manuscript. In parallel 
assays, L. monocytogenes INS7 and its enterocin CRL35-resistant clones were also conjugated 
with pNF1002-bearing E. coli SM10. 
2.3. Characterization of L. monocytogenes FBprfA* 
The growth of both L. monocytogenes FBUNT and L. monocytogenes FBprfA* was tested in 
minimal medium supplemented with 50 mM glucose [21]. For this purpose, starting cultures were 
grown overnight at 37ºC in TSB, then cells were harvested, washed twice and suspended in PBS. 
Minimal medium was then inoculated (1:100) and cell growth was monitored at 37°C for 24 h. This 
medium enhances the differences in growth rates between PrfA*-expressing Listeria cells and the 
saprophytic parental strains, since glucose is the only source of energy, and L. monocytogenes 
cells that express PrfA* heavily rely on sugar phosphates instead [22, 23]. In addition, growth in 
TSB medium was analyzed. L. monocytogenes expressing the L140F allele settles at the bottom of 
the culture tubes when growing in a rich culture medium [20]. Therefore, we analyzed this 
phenotype to confirm the correct generation of the PrfA* variant derived from L. monocytogenes 
FBUNT. The hemolytic activity of L. monocytogenes FBprfA* was also tested. Bacterial cultures 
were grown at 37°C till OD600nm=0.9. The culture supernatants were assayed for hemolytic activity 
as previously described [20]. The 100% control was achieved upon addition of 0.1% Triton X-100.  
2.4. RNA isolation and quantitative real-time PCR measurements 
L. monocytogenes FBUNT and L. monocytogenes FBprfA* cells were harvested at mid-exponential 
phase by centrifugation and washed with cold TE buffer, [24]. Cells were suspended in 500 µl of 
the same buffer and then the following reagents were sequentially added: 0.6 g of glass beads, 
170 µl of 2% macaloid slurry, 500 µl of TE saturated phenol with chloroform:isoamyl alcohol (1:1) 
and 50 µl of 10% SDS. Bacterial disruption was achieved in a Mini-Beadbeater Cell Disrupter 
(Model 607EUR, Biospec Products). After 15 min centrifugation at 12,000 x g, the aqueous 














and precipitated with 3 M sodium acetate and 3 volumes of absolute ethanol. Then, RNA was 
recovered by centrifugation, washed with 70% ethanol and dissolved in RNAse free water. Isolated 
RNA was treated with recombinant TurboTM DNAse (Ambion-Thermo Fischer Scientific) prior to 
cDNA synthesis according to the manufacturer's instructions. 
DNA-free RNA (1 µg) was used to synthesize cDNA using SuperScript® III First-Strand Synthesis 
SuperMix (Invitrogen, Thermo Fisher Scientific). qRT-PCR reactions were carried out in duplicate 
using 50 ng of cDNA, 0.3 µM of each primer and 10 µl of iQ™ SYBR® Green Supermix (Bio-Rad) 
for a final reaction volume of 20 µl. Reactions were performed in an iQ 5 Multicolor Real-Time PCR 
Detection System (Bio-Rad, USA) under the following conditions: 3 min at 95°C, 40 cycles of 20 
seg at 95°C, 20 seg at 52°C and 20 seg at 72 ºC, followed by melting curve cycles. For each 
reaction, non-template controls (NTC) were included. qPCR primers were designed with 
PrimerQuest® Tool from IDT (http://www.idtdna.com/primerquest/Home/Index), and are shown in 
Supplementary Table S1. The expression of the following genes was studied: mptC and mptD 
which encode the IIC and IID subunits of Man-PTS, respectively, prfA and hly (listeriolysin O gene). 
The set of primers used in these experiments were designed to be highly specific for mpt (see 
alignment in Supplementary information). The 16S rRNA gene was chosen as the housekeeping 
gene because its expression was invariable under the tested conditions. The changes in the 
expression of these genes in L. monocytogenes FBprfA* were expressed by means of the double 
ΔΔCT method [25]. 
2.5. Membrane proteomics 
L. monocytogenes FBUNT and L. monocytogenes FBprfA* were grown till mid-exponential phase 
in TSB medium at 37ºC and then they were harvested by centrifugation, washed twice with PBS 
and sonicated with 15 s pulses under nitrogen stream and keeping the samples at 0-4ºC. 
Afterward, unbroken cells and debris were discarded by centrifugation (20,000 x g for 30 minutes). 
The resulting supernatants were centrifuged at 150,000 x g in order to collect plasma membranes 
and the associated cell wall. Note that bacteria were not treated with lysozyme or pancreatic 
enzymes prior to plasma membrane isolation in order to avoid any artifact derived from a plausible 














ultracentrifugation were resuspended in double distilled water and protein content was measured 
by the Lowry method [26]. Then, membrane suspensions were dissolved with 2X Laemmli sample 
buffer (Sigma) and they were electrophoresed till the dye front entered 1 cm into the separation 
gel, which was prepared at 10%. Gels were stained with colloidal Coomassie G-250, the protein 
spots were excised and the proteomic study was carried out at the mass spectrometry facility of 
Cequibiem (UBA, Argentina) with a nanoHPLC coupled to a mass spectrometer with Orbitrap 
technology. Quantification of each protein was obtained using the proteome Discover software 
(Thermo Scientific) and the statistical analysis was done with Perseus free software [27].  
2.6. Membrane lipidomics 
All Listeria strains were grown at 37ºC till the end of exponential phase in 500 ml TSB culture 
medium supplemented with nalidixic acid. Cells were harvested by centrifugation at 8,000 x g 
during 20 min and washed twice with double distilled water. The bacterial pellets were 
resuspended in water, lyophilized overnight, then suspended in methanol-chloroform-water 
(2:1:0.8) mixture was sonicated for 2 minutes in a cold bath. Afterward, 1 ml of chloroform and 1 ml 
of 0.63% LiCl were added, and, the samples were vigorously vortexed for 30 minutes. The final 
solution was centrifuged at 2,000 x g for 10 minutes to form two layers. The bottom layer was 
carefully transferred to a new vial, dried under nitrogen and the resulting lipid film was stored at -
20oC until use. Phospholipid content was estimated by measuring phosphate, according to the 
Ames method [28]. The polar lipids of Listeria membranes were characterized by linear ion-trap 
(LIT) multiple-stage high resolution mass spectrometry (MSn), as described previously [29]. To 
determine the structures of the fatty acid substituents in the lipid, the lipid extraction was 
hydrolyzed with tetrabutylammonium hydroxide (40 wt% solution in water) in a centrifuge tube. 
After heating at 100 ºC for 60 min,1:1 0.63% LiCl/ hexane was added, vortexed, and centrifuged at 
1,200 x g for 2 min to form two layers. The upper layer, containing the free fatty acids, was 
transferred to a clean tube, dried under nitrogen and N-(4-aminomethylphenyl) pyridinium (AMPP) 
derivative was made with the AMP+ Mass Spectrometry Kit, according to the user’s instruction [29]. 
High resolution LIT MSn experiments were conducted on a Thermo Scientific LTQ Orbitrap Velos 














into the electrospray ion source where the needle was set at 4.0 kV and the temperature of the 
capillary was 300 ºC. Helium was used as the collision and the buffer gas. The mass spectra were 
accumulated in the profile mode, typically for 3-10 min for MSn spectra (n=2,3,4). 
2.7. Antimicrobial activity of enterocin CRL35 
Enterocin CRL35 and pediocin PA-1 were purified from the supernatants of Enterococcus mundtii 
CRL35 grown in LAPTg broth and Pediococcus acidilactici PAC1 grown in MRS broth, respectively. 
Both strains were cultured overnight at 30°C and bacteriocins were obtained by a two step protocol 
consisting in a precipitation with ammonium sulfate followed by reverse phase HPLC using a C18 
column with a non-linear gradient of acetonitrile [30]. Nisin was purchased from Sigma (Research 
AG, Argentina) and also purified by reverse phase HPLC C18. 
For viability assays, L. monocytogenes cultures were harvested at mid-exponential phase, cells 
were washed and suspended in 50 mM HEPES-K buffer, pH 7 to approximately 107 cells ml-1. 
Class IIa bacteriocins were added at a final concentration of 5 nM and cell suspensions were 
incubated for 30 min at 37°C. This peptide concentration was chosen because it allows a clear 
differentiation in the sensitivity of L. monocytogenes FBUNT and L. monocytogenes FBprfA*. Since 
FBUNT strain is already hypersensitive to class IIa, concentration of bacteriocin of 10 nM and 
higher results in complete elimination of these bacteria. In the experiments assessing sensitivity to 
nisin, this lantibiotic was used at a final concentration of 30 nM. 
Samples from culture supernatants were taken, serially diluted and plated onto TSB plates. 
Colonies were counted after 16–h incubation at 37°C according to Masias et al. [31]. In addition, 
sensitivity of L. monocytogenes INS7 wild type, L. monocytogenes INS7 R2 and L. monocytogenes 
INS7 R3 to enterocin CRL35 was also studied in order to analyze whether the expression of PrfA* 
leads to a change in the phenotype of these strains. Particularly, we focused on the sensitivity of 
the enterocin CRL35-resistant clones R2 and R3 [19].  
2.8. Binding of enterocin CRL35 to Listeria cells 
90 μl of 100 μM enterocin CRL35 solution was mixed with 10 μl of fluorescamine prepared in 
acetone (1 mg.ml-1) in an eppendorf tube wrapped in tin foil. After vigorous vortexing, the tube was 














activity displayed by the native peptide [31]. Cells of L. monocytogenes FBUNT and L. 
monocytogenes FBprfA* that have grown in TSB at 37°C were harvested by centrifugation, 
washed twice with HEPES-K buffer, pH 7.4, and kept on ice. Then, cell suspensions (109 cells.ml-1) 
were prepared in the same buffer and 200 nM fluorescent-labeled enterocin CRL35 was added. 
The peptide was allowed to be in contact with Listeria cells for 5 minutes and then fluorescence 
was measured in the supernatants as an indirect estimation of peptide binding. Control of enterocin 
CRL35 in a cell-free medium was used for calculating the percentage of unbound enterocin CRL35 
that remained in the supernatants. The λexc was set at 395 nm, whereas the λem was set at 475 nm. 
Fluorescence was monitored in an ISS PC1 spectrofluorimeter. These results were confirmed by 
measuring total fluorescence upon excitation at 395 nm by using a SLM 4048c fluorometer 
equipped with a 3-71 Corning filter placed right before the emission photomultiplier. 
2.9. Insertion of enterocin CRL35 into Listeria-derived lipid bilayers 
0.125 μmol of lipids extracted from both Listeria strains were dried under nitrogen, resuspended in 
250 μl of 20 mM Tris-HCl buffer containing 1 mM EDTA and vigorously vortexed till complete 
formation of multilamellar vesicles. Then, liposomes were sonicated 20 min and the small 
unilamellar vesicles (SUV) thus obtained were used within 3 h.  
Enterocin CRL35 was diluted in the same buffer till a final concentration of 1.5 μM and tryptophan 
spectra were taken upon addition of increasing concentrations of SUV, from 0 to 16 μM. Samples 
were excited at 280 nm and the measurements were carried out at 37°C in a ISS PC1 
spectrofluorometer. Raw spectra were corrected by substracting the scattering signals derived from 
liposomes. 
For assessing the affinity constants, we plotted the blue shift (Δλmax) against lipid concentration and 
data was fitted to a hyperbole using the following equation: 
β=
βmax.[ lipid]














where β is the tryptophan blue shift measured after each addition of lipids, βmax is the maximal blue 
shift (asymptote of the hyperbola), Kd is the affinity constant, which represents the lipid 
concentration ([lipid]) needed for reaching a 50% of the βmax. 
3. RESULTS 
3.1. L. monocytogenes grows poorly in glucose-based minimal medium upon introduction 
of PrfA* 
The constitutively activated prfA L140F allele was introduced into L. monocytogenes FBUNT, an 
enterocin CRL35 – sensitive indicator strain [18], by conjugation, as described by Wong and 
Freitag [20]. The resulting isolate, L. monocytogenes FBprfA*, bear pPL2-prfAL140F plasmid 
integrated within the tRNAArg gene in its chromosome (Fig. S1A and B). As expected, the resultant 
mutant strain displayed increased hemolytic activity (Fig. S1C) and autoaggregation phenotype 
when growing overnight in TSB medium (Fig. S1D).  
L. monocytogenes FBprfA* showed a fitness defect in TSB culture medium, as previously 
observed for other Listeria prfA* strains [32] (Fig. 1A). Most notably, it displayed a marked growth 
impairment in glucose-containing minimal medium, as reported for L. monocytogenes EGD-derived 
strains [32]. The FBprfA* mutant exhibited poor growth in the presence of glucose (Fig. 1B), 
suggesting that glucose transport is impaired by the presence of the activated prfA* allele. 
3.2. Expression of IIC and IID subunits of Man-PTS complex is reduced in L. 
monocytogenes FBprfA* 
Man-PTS is the physiological transporter of glucose in L. monocytogenes [33]. Therefore, the Man-
PTS expression could be downregulated after the introduction of prfA* in the FBUNT strain. Thus, 
we assessed the relative expression of membrane proteins of L. monocytogenes FBUNT and L. 
monocytogenes FBprfA* by means of a proteomic approach. At first, we analyzed all proteins 
corresponding to the Man-PTS systems present in Listeria (MptACD and MpoABCD) (Tables 1 and 
S2). In the case of MptA, MptC and MpoB proteins, no significant differences were detected 
between the two strains (p-value> 0.05). In contrast, MptD and MpoD levels were about 44 and 














operon, ManR and ResD, associated to the membrane fraction of L. monocytogenes FBprfA* 
samples (Table S3). Moreover, ManR was not detected in the membrane fraction of L. 
monocytogenes FBUNT, whereas ResD was expressed 3.66 fold higher in FBprfA* than FBUNT 
samples (Table S3). These results showed that Man-PTS proteins were down regulated in L. 
monocytogenes FBprfA*. It is important to note that a number of proteins increased their 
association to membranes upon expression of PrfA*, not only the virulence factors that are already 
known to be regulated by PrfA (Table S3). Among these proteins, several enzymes related to fatty 
acid synthesis were found in the membrane fraction, which is a puzzling finding based on the 
above results.  
We next analyzed the expression of mptC and mptD, encoding the IIC and IID subunits of the Man-
PTS, respectively, in L. monocytogenes FBprfA* using qRT-PCR. Expression of two PrfA-regulated 
genes, prfA itself and hly, was also measured. The level of both mptC and mptD transcripts was 
reduced by 65% in L. monocytogenes FBprfA* as compared to those observed in the parental 
strain (mptC 0.35 ± 0.07; mptD 0.38 ± 0.08). Consistent with the introduction of the constitutively 
activated prfA* allele, prfA and hly were overexpressed in L. monocytogenes FBprfA*. Indeed, the 
16-fold increase in hly gene expression (encoding the pore forming hemolysin listeriolysin O or 
LLO) explains the enhanced hemolytic activity of the virulent mutant strain (prfA 3.97 ± 0.66, hlyA 
16.59 ± 5.58). The prfA*-dependent reduction in the expression of mptC and mptD differs 
somewhat from that reported by Marr et al. [32]; however, their data were obtained from 
microarrays studies, which, in contrast to qPCR, usually cannot accurately distinguish relatively 
minor changes in gene expression levels [34]. 
3.3. L. monocytogenes containing constitutively activated PrfA are more sensitive to 
pediocin-like bacteriocins  
Since MptC/MptD (IIC/IID proteins of the Man-PTS) have been reported to constitute the class II 
bacteriocin receptor, we tested the sensitivity of our PrfA*-expressing strain to pediocin-like 
bacteriocins by performing killing curves analyses, according to the protocol reported by Masias et 
al. [31]. We observed less than 20% decrease in L. monocytogenes FBUNT colony forming units 
(CFU) after 30 min incubation with 5 nM enterocin CRL35. In contrast, more than 90% of the L. 














were obtained for pediocin PA-1 (Fig. S2). To confirm the increased sensitivity to class IIa 
bacteriocins, we next constructed another PrfA* mutant strain on a different Listeria background, 
but still sensitive to enterocin CRL35, L. monocytogenes INS7, and two bacteriocin – resistant 
derivatives which are Man-PTS-deficient [19]. L. monocytogenes INS7 became more sensitive to 
enterocin CRL35 following the introduction of prfA* (Fig. 3). However, INS7-derived resistant cells, 
with impaired expression of the bacteriocin receptor, did not become more sensitive upon 
expression of PrfA* (Fig. 3). Overall, these results support the hypothesis that the so-called 
receptor for class IIa bacteriocins is not the only factor that dictates how sensitive a certain strain 
is, but it is still important for the activity. Importantly, L. monocytogenes FBprfA* strain did not 
display any change in its sensitivity toward nisin (Fig. S3), strongly suggesting that the expression 
of activated PrfA did not influence the mechanism of action of lantibiotics. 
3.4. Membrane phospholipid composition changes upon expression of PrfA* 
A correlation between protein levels of Man-PTS components and sensitivity toward enterocin 
CRL35 and pediocin PA-1 was not observed. However, we did detect changes in the association to 
membranes of a number of enzymes related to lipid metabolism. Based on this result, we 
hypothesized that the two strains might have different lipid abundances. Therefore, we pursued a 
detailed analysis of the membrane lipids present in FBprfA* and FBUNT strains. For this purpose, 
we purified lipids from both strains and subsequently carried out a comprehensive lipidomic 
analysis using the approaches previously developed in our laboratory [29]. As shown in Table 2, 
some differences were found when PrfA* was expressed. For instance, phosphatidic acid family 
(PA), that is absent in wild type cells, was detected as a minor species in L. monocytogenes 
FBprfA* strain. Conversely, plasmalogen phosphatidylglycerol species that is prominent in L. 
monocytogenes FBUNT, is significantly lowered in the FBprfA* strain (Fig. 4). All the lipids present 
e.g., phosphatidylglycerol (PG), phosphatidic acid (PA), cardiolipin (CL) and 
digalactosyldiacylglycerol (DGDG) are negatively charged and no zwitterionic lipids such as lysyl-
cardiolipins previously described in L. monocytogenes was found [29]. Hence, difference in the 














The phospholipids present in both strains used in this study, including PG, CL, PA, and DGDG, 
contain 15:0- and 17:0-FA substituents at sn-1 or sn-2 of the glycerol backbone, respectively, 
(Table 2) as the dominant species, whose structures were identified as anteiso 17:0 (a-17:0) and 
anteiso 15:0 (a-15:0) fatty acids [29]. For example, ions at m/z 721, 707, and 693 represent 
a17:0/a15:0-, a17:0/16:0-, and a15:0/a15:0-PG, respectively. The major CL species observed at 
m/z 1323 and 1351 represent (a15:0/a15:0) (a17:0/a15:0)-CL and (a15:0/a17:0) (a17:0/a15:0)-CL, 
consistent with the observation of the ions of m/z 661.46 and 675.48, representing the doubly 
charged counterpart, respectively. We could not find marked differences in PG and CL between the 
two strains. However, L. monocytogenes FBprfA* consistently contained a 2-fold higher fraction of 
a17:0- and a15:0-FA as compared to FBUNT (data not shown in our repeated experiments). Based 
on the proteomic analysis, it is evident that several enzymes related to fatty acid synthesis such as 
acetyl-CoA carboxylase (AccC), the dehydratase FabZ, FabH that participates in the fatty acid 
elongation, the trans-2-enoyl-ACP reductase (FabI), also the reductase FabK1, the fatty acid 
kinases FakA and FakB2, were associated to the membrane fraction in L. monocytogenes FBprfA* 
samples. The observed changes in the FA profile is in accordance with the association of these 
enzymes of fatty acid synthesis. However, it remains unclear whether the increase of a17:0- and 
a15:0-FA in FBprfA* is related to the unknown activity of PrfA, the virulence master regulator in L. 
monocytogenes. 
3.5 Binding and insertion of enterocin CRL35 into Listeria plasma membranes 
In addition to differences in membrane composition, we had also observed unexpected changes in 
the membrane association of proteins related to bacterial cell wall synthesis upon expression of 
PrfA*, e.g. UDP-N-acetylmuramate--L-alanine ligase (MurC) and UDP-N-acetylglucosamine 1-
carboxyvinyltransferase 1 (MurA1) (Table S3, Supplementary information). The bacteriocin bound 
both cell types, i.e. FBprfA*and FBUNT at the same degree, based on the estimations obtained 
with the fluorescent derivative of enterocin CRL35 (Fig. 5A). In fact, Listeria cells bound one third 
of the total peptides regardless the expression of PrfA* with the concomitant reduction in the cell 
wall net negative charge and the reduced expression of the bacteriocin receptor.  
Since the antimicrobial activity of bacteriocins is related to the insertion of these peptides into 














decided to analyze whether enterocin CRL35 would bind and insert the lipid bilayer of both Listeria 
strains (FBUNT and FBprfA*) besides its association to the bacterial outer surface structures. To 
this end, liposomes were prepared from Listeria lipids and the penetration of enterocin CRL35 into 
the membrane was assessed by taking advantage of a very well-known property of tryptophan 
(Fig. 5B); its fluorescence spectrum undergoes a blue shift when enters a more hydrophobic/apolar 
environment [11]. The affinity for lipids estimated was obtained from the binding curve of 
experimental data. Our results conclusively show that the affinity of enterocin CRL35 for FBprfA* 
lipids is 4 times higher than for FBUNT lipids (Kd FBUNT: 18.83 μM Vs. Kd FBprfA*: 4.46 μM). This 
result can explain the higher sensitivity of L. monocytogenes FBprfA* to enterocin CRL35 as 
compared to L. monocytogenes FBUNT. 
4. Discussion 
We showed that bacteria expressing prfA* have a marked reduction in the expression of Man-PTS 
genes and yet they are even more susceptible to pediocin-like peptides. One of the first 
mechanisms proposed to explain pore formation was based on the premise that Man-PTS acts as 
an anchor for pediocin-like bacteriocins, helping these peptides to reach the plasma membrane 
and eventually alter membrane permeability [35]. Later, this model was modified [4,6], and the 
concept that pediocin-like bacteriocins may induce a conformational change in the Man-PTS that 
leads to pore opening was proposed [36,37].  
In the present work, we demonstrated that the overexpression of prfA* resulted in a partial 
downregulation of Man-PTS complex based on the qPCR results. Besides, two transcription 
factors involved in the expression of the mptACD operon, i.e., ResD and ManR, were associated to 
the plasma membrane in L. monocytogenes FBprfA*. Since it has been reported that some 
transcription factors are associated to membranes when inactive [38], this finding agrees with Man-
PTS mRNA expression results. Furthermore, we were able to detect by mass spectrometry a 
significant downregulation of the IID subunit, which further supports the conclusion that Man-PTS 
complex expression is compromised in L. monocytogenes FBprfA* cells. Interestingly, we found a 
reduction in the expression of the IID subunit encoded by the mpt operon and also in the homolog 














The partial reduction in the expression of Man-PTS should impair pore formation, if this complex 
were the only proteins involved in this structure. Our results suggest a different mechanism, and 
support the model in which Man-PTS acts just as a docking molecule that brings bacteriocins to 
the plasma membrane for the subsequent aggregation into a pore. In this regard, Barraza et al. 
[39] have demonstrated that Man-PTS can be dispensable in the bacteriocin mechanism of action, 
and their results also favored a role as a mere docking molecule for Man-PTS [39]. These 
conclusions were based on experiments carried out in Escherichia coli cells that heterologously 
expressed the munA gene fused to another docking protein. We propose that Man-PTS would be 
part of the mechanism of action, since no bactericidal activity is displayed by enterocin CRL35 
when no receptor is expressed in L. monocytogenes. In fact, the results obtained with L. 
monocytogenes INS7-derived resistant cells support the contribution of Man-PTS to enterocin 
CRL35 sensitivity, presumably to ensure binding and insertion of antimicrobial peptides into the 
plasma membrane of target cells. However, the increased sensitivity of PrfA* strains suggests that 
some other PrfA-regulated component enhance sensitivity to bacteriocins when PrfA is activated. 
The lipidomic analysis shed some light on the differences in the plasma membranes of the two 
Listeria strains, which may help understand the sensitivities observed to class IIa bacteriocins. For 
instance, phosphatidic acid was present only in PrfA, being absent in FBUNT and it is tempting to 
speculate that PA might have an important role. In addition, the decrease in plasmalogen PG in 
FBPrfA* may also be crucial. Plasmalogen phospholipids have been thought to confer certain 
protection against extreme pH, high temperatures, organic solvents and antibiotics [40,41]. 
Therefore, the abrupt reduction of plasmalogens in L. monocytogenes FBprfA* may predispose this 
strain to be more sensitive to class IIa peptides. So far, phosphatidylglycerol and cardiolipin are the 
only two phospholipid families taken into account for analyzing sensitivity of bacteriocins to Listeria 
[42]. Conversely, the lysinylation of these phospholipids is associated to increased resistance 
because of the positive charge that is introduced [8]. 
PA contains a large negative curvature that can form HII phase or cubic phase [43]. On the 
contrary, PG, the main phospholipid in Listeria is a lipid with a small curvature that can form a 
lamellar phase, which is a typical lipid bilayer. It has been reported that a hybrid bacteriocin 














with a concomitant disruption of the bilayer [44]. Thus, if enterocin CRL35 interacts with 
membranes in the same manner, even a slight increase in PA could enhance the membrane 
disruption triggered by the cationic peptides. 
In the same context, the increase of the major a 17:0- and a-15:0-FA in L. monocytogenes FBprfA* 
can increase the total negative charge of its membrane; more importantly, these FFA can also 
change the properties of the bilayer. It has been suggested that the addition of fatty acids to 
cylindrical phospholipids, such as phosphatidylcholine (and probably this can also be applied to 
PG), induces type II lyotropic liquid crystalline phases, such as the inverse bicontinuous cubic 
phases and the inverse hexagonal phase [45,46]. Therefore, the presence of fatty acids in the 
plasma membrane of Listeria can play a significant role in the interaction of class IIa bacteriocins 
with these cells and in their mechanism of action. In this regard, Marr et al. [32] reported that the 
expression of several enzymes associated with fatty acid synthesis and metabolism was increased 
in cells expressing PrfA*. Even though they did not analyze the membrane composition, their 
microarray assays led to speculate that some changes in the plasma membrane should take place. 
For instance, they found that fabH gene was upregulated. This gene is known to encode the 
enzyme that carries out the condensation reaction in the initiation of type II fatty acid biosynthesis 
[47]. Therefore, any change in its expression can have important consequences in the architecture 
of Listeria membrane. We found an increased fraction of FabH associated with FBprfA* 
membranes. It is important to note that FabH in Listeria is related to the synthesis of anteiso 
branched-chain fatty acids [48]. The increase of anteiso FFA (e.g., a17:0 and a15:0FA) and PA in 
the plasma membrane of FBprfA*, as observed in this study, is therefore in accordance with the 
fact that the FabH enzymes involved in FFA synthesis are intriguingly bound to plasma 
membranes, suggesting that an increase in turnover of these lipids induced by PrfA* may have 
occurred. The binding and insertion measurements of enterocin CRL35 to liposomes prepared 
from both L. monocytogenes FBUNT and L. monocytogenes FBprfA* lipids may reflect different 
composition of both membranes. We hypothesize that lipid composition might dictate the sensitivity 















In agreement with our findings, López-Solanilla et al. [49] also reported an enhanced susceptibility 
of a L. monocytogenes PrfA* strain only to potato defensin. However, no changes were reported by 
the same authors with other antimicrobial peptides of animal and vegetal origin, such as thionins, 
magainin and human defensins. In addition, there are no reports about sensitivity of L. 
monocytogenes PrfA* strain to bacterial-derived antimicrobial peptides such as pediocin-like 
bacteriocins. Nonetheless, that virulent L. monocytogenes are more sensitive to these compounds 
is an issue that deserves more attention. This focus may lead to design ways to use these peptides 
instead of antibiotics for clinical interventions, thus avoiding drastic alterations in the patient’s 
natural microbiota. We and others have tested bacteriocins in mice infected with L. monocytogenes 
with promising results [18,50,51]. By oral administration, Dabour et al. [52] have successfully 
treated infected mice with pediocin PA-1. Our success in the treatment of L. monocytogenes 
infections in mice with bacteriocins may be explained by the enhanced sensitivity of the virulent L. 
monocytogenes following activation of PrfA within host cells. 
In summary, we have proved that L. monocytogenes cells expressing active PrfA are more 
sensitive to class IIa peptides than Listeria cells in saprophytic state. This unexpected result raises 
questions about current models regarding receptor(s) for class IIa peptides and how these 
bacteriocins interact with bacterial membranes. For the first time, a study provides a link between 
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Figure 1. Differential growth kinetics of Listeria cells upon expression of PrfA*. L. 
monocytogenes FBUNT (■) and L. monocytogenes FBprfA* (●) were grown overnight and then 
collected, washed in PBS and inoculated in TSB medium (A), and in a glucose-containing minimal 
medium (B). Bacterial growth at 37 °C was followed for up to 24 h by measuring the OD at 600 nm. 
The results presented here are representative of three independent experiments. 
Figure 2. L. monocytogenes FBprfA* displays higher sensitivity to bactericidal activity of 
enterocin CRL35 compared to L. monocytogenes FBUNT. Cells were grown in TSB at 37 °C till 
mid-exponential phase. Then, cells were collected by centrifugation, washed and suspended in 
HEPES-K at 107 cells ml-1. Enterocin CRL35 was added at a final concentration of 5 nM, and 
aliquots of cell suspensions were serially diluted and plated onto TSB agar plates after 30 minutes 
of incubation at 37 °C. Values shown are mean ± standard deviation of three independent assays 
carried out in triplicate. Significantly different values compared to the corresponding control are 
indicated by * (α = 0.05). 
Figure 3. Sensitivity toward enterocin CRL35 of L. monocytogenes INS7 and its enterocin 
CRL35-resistant derivatives. L. monocytogenes INS7 (R2 and R3) were conjugated with E. coli 
SM10 bearing pNF1002 as described in Materials and methods for L. monocytogenes FBUNT. 
Bacteria grown till exponential phase were washed and suspended in HEPES-K at 107 cells ml-1. 
Enterocin CRL35 was added at a final concentration of 5 nM in the case of L. monocytogenes 
INS7 and at a concentration as high as 100 µM for the resistant isolates. Samples of each 
suspension were serially diluted and plated onto TSB agar plates after 30 minutes of incubation at 
37 °C. Values shown are mean ± standard deviation of three independent assays carried out in 
duplicate. Significantly different values compared to the corresponding control are indicated by * (α 
= 0.05). 
Figure 4. Plasmalogen PG content in plasma membranes. The relative abundance of pPG 
species was estimated by mass spectrometry as described in Materials and methods. Results 














is represented in black bars and FBprfA* in gray bars. This figure is representative of three 
independent experiments. 
Figure 5. Binding of enterocin CRL35. Listeria cells were grown in TSB medium, harvested by 
centrifugation and suspended in HEPES-K buffer. These cells were incubated with 2 µM 
fluorescamine-labeled enterocin CRL35 and supernatants were collected by centrifugation and 
fluorescence was measured as indicated in Materials and methods. Unbound enterocin CRL35 
was calculated as the percentage of initial enterocin CRL35, prior to the addition of bacteria (A). 
Influence of lipid composition on the binding of enterocin CRL35 to lipid vesicles. Tryptophan 
fluorescence blue shifts (Δλmax) were recorded in the presence of increasing concentrations of lipid 
vesicles derived from L. monocytogenes FBUNT (■) and FBprfA* (●). The means and standard 















Table 1. Relative expression of ManPTS proteins in Listeria PrfA* compare to FBUNT. 
Accession 
number 







Q8YAM2 lmo0096 protein mptA 0.1539 0.69 1.43 
Q8YAM1 lmo0097 protein mptC 0.9484 0.96 1.04 
Q8YAM0 lmo0098 protein mptD 0.0189 0.64 1.55 
Q8Y8W1 lmo0781 protein mpoD 0.0089 0.69 1.44 















Table 2. Lipidomic analysis of FBUNT and FBprfA* plasma membranes. 
FBUNT FBprfA* 
    Measured m/z Da Rel. Intensity % Measured m/z Da Rel. Intensity % Theo. Mass Da Deviation mDa Elemental Composition Structures 
640.4 0.13 640.4 0.11 640.4 0.26 C68 H130 O17 P2  (15:0/14:0)(15:0/15:0)-CL 
647.4 0.37 647.4 0.51 647.4 0.38 C69 H132 O17 P2  (15:0/15:0)(15:0/15:0)-CL 
654.4 0.32 654.4 0.43 654.4 0.4 C70 H134 O17 P2  (15:0/15:0)(16:0/15:0)-CL 
661.4 1.92 661.4 2.07 661.4 0.42 C71 H136 O17 P2  (15:0/15:0)(17:0/15:0)-CL 
668.4 0.78 668.4 0.85 668.4 0.4 C72 H138 O17 P2  (16:0/15:0)(15:0/15:0)-CL 
675.4 3.6 675.4 3.26 675.4 0.36 C73 H140 O17 P2  (17:0/15:0)(17:0/15:0)-CL 
682.4 0.21 682.4 0.15 682.4 0.5 C74 H142 O17 P2  (17:0/15:0)(17:0/16:0)-CL 
689.4 0.57 689.4 0.29 689.4 0.51 C75 H144 O17 P2  (17:0/15:0)(17:0/17:0)-CL 
    1281.8 0.1 1281.8 1.37 C68 H131 O17 P2  (15:0/14:0)(15:0/15:0)-CL 
1295.9 0.13 1295.9 0.28 1295.9 1.5 C69 H133 O17 P2  (15:0/15:0)(15:0/15:0)-CL 
1309.9 0.09 1309.9 0.22 1309.9 1.55 C70 H135 O17 P2  (15:0/15:0)(16:0/15:0)-CL 
1323.9 0.5 1323.9 1.11 1323.9 1.41 C71 H137 O17 P2  (15:0/15:0)(17:0/15:0)-CL 
1337.9 0.23 1337.9 0.41 1337.9 1.76 C72 H139 O17 P2  (16:0/15:0)(17:0/15:0)-CL 
1351.9 0.91 1351.9 1.3 1351.9 1.33 C73 H141 O17 P2  (17:0/15:0)(17:0/15:0)-CL 
1365.9 0.05     1365.9 2.3 C74 H143 O17 P2  (17:0/15:0)(17:0/16:0)-CL 
1379.9 0.15 1379.9 0.19 1379.9 1.34 C75 H145 O17 P2  (17:0/15:0)(17:0/17:0)-CL 
535.3 0.26 535.3 0.61 535.3 0.14 C54 H104 O16 P2  (15:0/0)(15:0/15:0)-CL 
542.3 0.06 542.3 0.23 542.3 0.09 C55 H106 O16 P2  (16:0/0)(15:0/15:0)-CL 
549.3 0.56 549.3 1.37 549.3 0.17 C56 H108 O16 P2  (15:0/0)(17:0/15:0)-CL 
    556.3 0.08 556.3 0.05 C57 H110 O16 P2  (16:0/0)(17:0/15:0)-CL 
563.3 0.08     563.3 0.18 C57 H108 O17 P2  (17:0/0)(17:0/15:0)-CL 
1071.6 0.09 1071.6 0.6 1071.6 0.67 C54 H105 O16 P2  (15:0/0)(15:0/15:0)-CL 
1085.7 0.05 1085.7 0.24 1085.7 0.73 C55 H107 O16 P2  (16:0/0)(15:0/15:0)-CL 
1099.7 0.25 1099.7 1.3 1099.7 0.63 C56 H109 O16 P2  (15:0/0)(17:0/15:0)-CL 
    1127.7 0.12 1127.7 1.06 C58 H113 O16 P2  (17:0/0)(17:0/15:0)-CL 
 
 
Table 2 (continued) 
FBUNT FBprfA*     
Measured m/z Da Rel. Intensity % Measured m/z Da Rel. Intensity % Theo. Mass Da Deviation mDa Elemental Composition Structures 
423.2 0.07 423.2 0.63 423.2 -0.12 C39 H76 O15 P2  (15:0/0)(15:0/0)-CL 
847.4 0.05 847.4 0.69 847.4 0.51 C39 H77 O15 P2  (15:0/0)(15:0/0)-CL 
    875.5 0.08 875.5 0.79 C41 H81 O15 P2  (17:0/0)(15:0/0)-CL 
    619.4 0.22 619.4 0.58 C33 H64 O8 P  15:0/15:0-PA 
    647.4 0.4 647.4 0.85 C35 H68 O8 P  17:0/15:0-PA 
679.4 1.68 679.4 1.96 679.4 0.4 C35 H68 O10 P  15:0/14:0-PG 
693.4 27.02 693.4 32.69 693.4 0.28 C36 H70 O10 P  15:0/15:0-PG 
707.4 13.35 707.4 15.47 707.4 0.4 C37 H72 O10 P  16:0/15:0-PG 
719.4 0.52 719.4 0.64 719.4 0.44 C38 H72 O10 P  17:1/15:0-PG 
721.5 100 721.5 100 721.5 -0.01 C38 H74 O10 P  17:0/15:0-PG 
733.5 1.05 733.5 1.13 733.5 0.2 C39 H74 O10 P  18:0/15:0-PG 














749.5 10.52 749.5 7.39 749.5 0.39 C40 H78 O10 P  17:0/17:0-PG 
663.4 0.57 663.4 0.11 663.4 0.44 C35 H68 O9 P  p14:0/15:0-PG 
677.4 14.11 677.4 1.63 677.4 0.39 C36 H70 O9 P  p15:0/15:0-PG 
691.4 8.41 691.4 1.01 691.4 0.51 C37 H72 O9 P  p16:0/15:0-PG 
705.5 61.3 705.5 7.55 705.5 0.35 C38 H74 O9 P  p17:0/15:0-PG 
719.5 0.81 719.5 0.09 719.5 0.5 C39 H76 O9 P  p16:0/17:0-PG 
733.5 2.54 733.5 0.25 733.5 0.2 C40 H78 O9 P  p17:0/17:0-PG 
    917.6 0.06 917.6 0.66 C51 H98 O11 P  15:0-15:0/15:0-PG 
    931.7 0.06 931.7 0.43 C52 H100 O11 P  16:0-15:0/15:0-PG 
945.7 0.13 945.7 0.17 945.7 0.71 C53 H102 O11 P  15:0-17:0/15:0-PG 
959.7 0.1 959.7 0.11 959.7 0.68 C54 H104 O11 P  15:0-17:0/16:0-PG 
737.4 0.3 737.4 0.38 737.4 0.1 C39 H74 O10 Cl  MGDG 
891.6 0.09 891.6 0.24 891.6 0.45 C47 H87 O15  17:0/15:0-DGDG 
899.5 0.14 899.5 0.56 899.5 0.39 C45 H84 O15 Cl  15:0/15:0-DGDG-Cl 
927.5 0.49 927.5 1.27 927.5 0.46 C47 H88 O15 Cl  17:0/15:0-DGDG-Cl 
















 Up to date class IIa bacteriocins sensitivity was evaluated in saprophytic Listeria.  
 Listeria overexpressing prfA shows partially reduced expression of Man-PTS complex.  
 Sensitivity to pediocin-like bacteriocins is increased in pathogenic Listeria cells. 
 Phosphatidic acid and plasmalogen are key players in the bacteriocin mode of action.  
 A link between virulence and sensitivity toward antilisterial peptides is proposed. 
ACCEPTED MANUSCRIPT
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
